-transparent.png){kind=logo}
Eighteen patients were treated with escalating doses of recombinant, Escherichia coli-derived human interleukin-6 (IL-6) intravenously every 8 h. Therapy was given for two cycles of 7 days each separated by a week off therapy. Fevers and chills were observed in most patients. Mild renal and liver function abnormalities were noted at higher doses of IL-6. Dose-limiting toxicity was reached at 30 micrograms/kg i.v. every 8 h due to reversible neurotoxicity, but significant rapidly reversible anemia and hyperglycemia were seen at lower doses. Platelet counts, white blood cell counts, and acute phase reactant levels were substantially elevated. No antitumor responses were seen. A maximum tolerated dose of 10 micrograms/kg i.v. every 8 h for two 7-day cycles is recommended for future phase II trials.
J Weber, and
H Gunn, and
J Yang, and
D Parkinson, and
S Topalian, and
D Schwartzentruber, and
S Ettinghausen, and
D Levitt, and
S A Rosenberg
September 1999,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J Weber, and
H Gunn, and
J Yang, and
D Parkinson, and
S Topalian, and
D Schwartzentruber, and
S Ettinghausen, and
D Levitt, and
S A Rosenberg
May 1993,
Cancer,
J Weber, and
H Gunn, and
J Yang, and
D Parkinson, and
S Topalian, and
D Schwartzentruber, and
S Ettinghausen, and
D Levitt, and
S A Rosenberg
February 2023,
Cancer research communications,
J Weber, and
H Gunn, and
J Yang, and
D Parkinson, and
S Topalian, and
D Schwartzentruber, and
S Ettinghausen, and
D Levitt, and
S A Rosenberg
July 1985,
Cancer,
J Weber, and
H Gunn, and
J Yang, and
D Parkinson, and
S Topalian, and
D Schwartzentruber, and
S Ettinghausen, and
D Levitt, and
S A Rosenberg
March 1997,
Clinical cancer research : an official journal of the American Association for Cancer Research,
J Weber, and
H Gunn, and
J Yang, and
D Parkinson, and
S Topalian, and
D Schwartzentruber, and
S Ettinghausen, and
D Levitt, and
S A Rosenberg
June 2009,
Clinical cancer research : an official journal of the American Association for Cancer Research,
J Weber, and
H Gunn, and
J Yang, and
D Parkinson, and
S Topalian, and
D Schwartzentruber, and
S Ettinghausen, and
D Levitt, and
S A Rosenberg
December 1987,
Cancer treatment reports,
J Weber, and
H Gunn, and
J Yang, and
D Parkinson, and
S Topalian, and
D Schwartzentruber, and
S Ettinghausen, and
D Levitt, and
S A Rosenberg
September 1978,
Cancer treatment reports,
J Weber, and
H Gunn, and
J Yang, and
D Parkinson, and
S Topalian, and
D Schwartzentruber, and
S Ettinghausen, and
D Levitt, and
S A Rosenberg
January 1980,
Cancer treatment reports,
J Weber, and
H Gunn, and
J Yang, and
D Parkinson, and
S Topalian, and
D Schwartzentruber, and
S Ettinghausen, and
D Levitt, and
S A Rosenberg
August 1993,
British journal of cancer,
